Latest pharmaceutical industry Stories
WOODCLIFF LAKE, N.J., May 8, 2013 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Thursday, May 16, 2013, at 10:00 a.m. EDT to review its results of operations for the quarter ended March 31, 2013. Par is privately held and does not generally make its financial information available to the public. However, holders of Par's debt securities, certain prospective holders of Par's debt securities and research analysts who cover or...
CRANBURY, N.J., May 8, 2013 /PRNewswire/ -- Oncobiologics, Inc. announced today that Zhejiang Huahai Pharmaceutical Co., Ltd and Oncobiologics have signed an alliance agreement for the development, manufacture and commercialization of biosimilar monoclonal antibody products. The scope of the agreement includes exclusive commercialization by Huahai of four biosimilars developed by Oncobiologics and manufactured in China at a Huahai biologics facility for the China market, and will...
MALVERN, Pa., May 8, 2013 /PRNewswire/ -- Egalet Ltd., a privately held specialty pharmaceutical company focused on developing safe, effective and abuse-deterrent medications, announced today the appointment of Stan Musial as chief financial officer (CFO). "The addition of Stan to the management team comes at a critical time as the most advanced products in Egalet's pipeline of abuse-deterrent opioids are nearing phase 3," said Bob Radie, president and CEO. "Stan's finance...
BOULDER, Colo., May 8, 2013 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Bank of America Merrill Lynch Healthcare Conference in Las Vegas and the UBS Global Healthcare conference in New York City. The public is welcome to participate in the conferences through webcasts on the Array BioPharma website: www.arraybiopharma.com. (Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO)...
The industry will get a boost during the economic recovery, when improvements in corporate profit and sentiment are expected to create renewed demand for promotional products; though, growing competition from low-cost manufacturers that deal directly with clients will force operators to differentiate themselves by using greener materials in their products or by increasing their web presence to enhance client interaction. For these reasons, industry research firm IBISWorld has updated a...
Drug manufacturer Merck recently sought and earned U.S. Food and Drug Administration approval for a new drug that pairs its own cholesterol-lowering Zetia with a generic version of Lipitor, the blockbuster statin marketed by Pfizer before it lost patent protection in 2011. The Rottenstein Law Group, which represents clients in Lipitor lawsuits, is watching this development closely, noting that studies have established a link between Lipitor and Type 2 diabetes. (PRWEB) May 07, 2013 Drug...
All amounts are in U.S. dollars (unless otherwise noted) QUEBEC CITY, May 7, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company"), a late stage drug development company specializing in oncology and endocrinology, today reported financial and operating results as at and for the first quarter ended March 31, 2013. Key Drug Developments AEZS-108 (Doxorubicin Peptide Conjugate) -- First patient treated for Phase 2 trial in...
PARSIPPANY, N.J., May 7, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Actavis' President and Chief Executive Officer, will provide an overview and update of the Company's business at the Bank of America Merrill Lynch 2013 Health Care Conference on Tuesday, May 14, 2013 at 8:40 AM Pacific Time at the Encore at the Wynn in Las Vegas, Nevada. The presentation will be webcast live and can be accessed on...
AMSTERDAM, May 7, 2013 /PRNewswire/ -- Co-located events P-MEC/ICSE/BioPh/InnoPack/LABWorld are helping to build improved partnerships and drive GMP standards across the region CPhI announces that CPhI China [http://www.cphi-china.com ], an event organised by UBM Live and UBM Sinoexpo, is returning to the Shanghai New International Expo Center (25-27 June 2013, Shanghai) for the 13th consecutive year - with an increased scale, more informative exhibition and regional...
By Jake Newberger, A mechanical engineer with specialties in robotics and automatic control systems WASHINGTON DC, May 7, 2013 /PRNewswire/ -- Process Analytical Technology (PAT) is quickly becoming an integral component in the pharmaceutical and chemical manufacturing industries. Utilizing a low latency network of powerful chemometric instruments, multivariate data analysis software, process control tools, and a central SQL database, PAT provides pharmaceutical and...
